Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05361967 · ClinicalTrials.gov registry record
Tack Optimized Balloon Angioplasty Post-Market Study
A clinical trial, sponsored by Spectranetics Corporation.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05361967 is a clinical trial that was terminated before completion, run by Spectranetics Corporation. The registered enrollment target is 6 participants.
The verdict
NCT05361967 was terminated before completion, sponsored by Spectranetics Corporation.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to obtain outcomes following dissection repair with the Tack Endovascular System in a broad population of patients undergoing endovascular treatment of lesions within the superficial femoral, popliteal, peroneal, and/or tibial arteries.
Interventions
- DEVICE The Tack Endovascular System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-03-30 |
| Est. Completion | 2024-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05361967
The ClinicalTrials.gov registry entry for NCT05361967 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spectranetics Corporation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Tack Endovascular System is the first listed.
NCT05361967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05361967 about?
NCT05361967 is a clinical study titled "Tack Optimized Balloon Angioplasty Post-Market Study". The objective of this study is to obtain outcomes following dissection repair with the Tack Endovascular System in a broad population of patients undergoing endovascular treatment of lesions within the superficial femoral, popliteal, peroneal, and/or tibial arteries.
What is the current status of trial NCT05361967?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2023-03-30. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05361967?
The interventions under investigation include: The Tack Endovascular System (DEVICE).
Who is sponsoring clinical trial NCT05361967?
This trial is sponsored by Spectranetics Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.